#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Perforin and IL-2 Upregulation Define Qualitative Differences among Highly Functional Virus-Specific Human CD8 T Cells


The prevailing paradigm of T lymphocyte control of viral replication is that the protective capacity of virus-specific CD8+ T cells is directly proportional to the number of functions they can perform, with IL-2 production capacity considered critical. Having recently defined rapid perforin upregulation as a novel effector function of antigen-specific CD8+ T cells, here we sought to determine whether new perforin production is a component of polyfunctional CD8+ T cell responses that contributes to the control of several human viral infections: cytomegalovirus (CMV), Epstein-Barr virus (EBV), influenza (flu), and adenovirus (Ad). We stimulated normal human donor PBMC with synthetic peptides whose amino acid sequences correspond to defined CTL epitopes in the aforementioned viruses, and then used polychromatic flow cytometry to measure the functional capacity and the phenotype of the responding CD8+ T cells. While EBV and flu-specific CD8+ T cells rarely upregulate perforin, CMV-specific cells often do and Ad stimulates an exceptionally strong perforin response. The differential propensity of CD8+ T cells to produce either IL-2 or perforin is in part related to levels of CD28 and the transcription factor T-bet, as CD8+ T cells that rapidly upregulate perforin harbor high levels of T-bet and those producing IL-2 express high amounts of CD28. Thus, “polyfunctional” profiling of antigen-specific CD8+ T cells must not be limited to simply the number of functions the cell can perform, or one particular memory phenotype, but should actually define which combinations of memory markers and functions are relevant in each pathogenic context.


Vyšlo v časopise: Perforin and IL-2 Upregulation Define Qualitative Differences among Highly Functional Virus-Specific Human CD8 T Cells. PLoS Pathog 6(3): e32767. doi:10.1371/journal.ppat.1000798
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000798

Souhrn

The prevailing paradigm of T lymphocyte control of viral replication is that the protective capacity of virus-specific CD8+ T cells is directly proportional to the number of functions they can perform, with IL-2 production capacity considered critical. Having recently defined rapid perforin upregulation as a novel effector function of antigen-specific CD8+ T cells, here we sought to determine whether new perforin production is a component of polyfunctional CD8+ T cell responses that contributes to the control of several human viral infections: cytomegalovirus (CMV), Epstein-Barr virus (EBV), influenza (flu), and adenovirus (Ad). We stimulated normal human donor PBMC with synthetic peptides whose amino acid sequences correspond to defined CTL epitopes in the aforementioned viruses, and then used polychromatic flow cytometry to measure the functional capacity and the phenotype of the responding CD8+ T cells. While EBV and flu-specific CD8+ T cells rarely upregulate perforin, CMV-specific cells often do and Ad stimulates an exceptionally strong perforin response. The differential propensity of CD8+ T cells to produce either IL-2 or perforin is in part related to levels of CD28 and the transcription factor T-bet, as CD8+ T cells that rapidly upregulate perforin harbor high levels of T-bet and those producing IL-2 express high amounts of CD28. Thus, “polyfunctional” profiling of antigen-specific CD8+ T cells must not be limited to simply the number of functions the cell can perform, or one particular memory phenotype, but should actually define which combinations of memory markers and functions are relevant in each pathogenic context.


Zdroje

1. AmyesE

HattonC

Montamat-SicotteD

GudgeonN

RickinsonAB

2003 Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection. J Exp Med 198 903 911

2. CallanMF

2003 The evolution of antigen-specific CD8+ T cell responses after natural primary infection of humans with Epstein-Barr virus. Viral Immunol 16 3 16

3. BelzGT

DohertyPC

2001 Virus-specific and bystander CD8+ T-cell proliferation in the acute and persistent phases of a gammaherpesvirus infection. J Virol 75 4435 4438

4. DohertyPC

ChristensenJP

BelzGT

StevensonPG

SangsterMY

2001 Dissecting the host response to a gamma-herpesvirus. Philos Trans R Soc Lond B Biol Sci 356 581 593

5. GillespieGM

WillsMR

AppayV

O'CallaghanC

MurphyM

2000 Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors. J Virol 74 8140 8150

6. GuidottiLG

IshikawaT

HobbsMV

MatzkeB

SchreiberR

1996 Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4 25 36

7. GuidottiLG

RochfordR

ChungJ

ShapiroM

PurcellR

1999 Viral clearance without destruction of infected cells during acute HBV infection. Science 284 825 829

8. MoriyamaT

GuilhotS

KlopchinK

MossB

PinkertCA

1990 Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 248 361 364

9. LechnerF

WongDK

DunbarPR

ChapmanR

ChungRT

2000 Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191 1499 1512

10. ThimmeR

BukhJ

SpangenbergHC

WielandS

PembertonJ

2002 Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci U S A 99 15661 15668

11. MakedonasG

BettsMR

2006 Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection. Springer Semin Immunopathol 28 209 219

12. SederRA

DarrahPA

RoedererM

2008 T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 8 247 258

13. HarariA

DutoitV

CelleraiC

BartPA

Du PasquierRA

2006 Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol Rev 211 236 254

14. PantaleoG

HarariA

2006 Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nat Rev Immunol 6 417 423

15. ZimmerliSC

HarariA

CelleraiC

VallelianF

BartPA

2005 HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc Natl Acad Sci U S A 102 7239 7244

16. DarrahPA

PatelDT

De LucaPM

LindsayRW

DaveyDF

2007 Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 13 843 850

17. HeuselJW

WesselschmidtRL

ShrestaS

RussellJH

LeyTJ

1994 Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76 977 987

18. PodackER

YoungJD

CohnZA

1985 Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules. Proc Natl Acad Sci U S A 82 8629 8633

19. PetersPJ

BorstJ

OorschotV

FukudaM

KrahenbuhlO

1991 Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J Exp Med 173 1099 1109

20. ShiverJW

HenkartPA

1991 A noncytotoxic mast cell tumor line exhibits potent IgE-dependent cytotoxicity after transfection with the cytolysin/perforin gene. Cell 64 1175 1181

21. BolithoP

VoskoboinikI

TrapaniJA

SmythMJ

2007 Apoptosis induced by the lymphocyte effector molecule perforin. Curr Opin Immunol 19 339 347

22. VoskoboinikI

SmythMJ

TrapaniJA

2006 Perforin-mediated target-cell death and immune homeostasis. Nat Rev Immunol 6 940 952

23. HerspergerAR

MakedonasG

BettsMR

2008 Flow cytometric detection of perforin upregulation in human CD8 T cells. Cytometry A

24. MakedonasG

BanerjeePP

PandeyR

HerspergerAR

SanbornKB

2009 Rapid up-regulation and granule-independent transport of perforin to the immunological synapse define a novel mechanism of antigen-specific CD8+ T cell cytotoxic activity. J Immunol 182 5560 5569

25. LeenAM

SiliU

VaninEF

JewellAM

XieW

2004 Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells. Blood 104 2432 2440

26. Crawford-MikszaL

SchnurrDP

1996 Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues. J Virol 70 1836 1844

27. SmythMJ

KellyJM

SuttonVR

DavisJE

BrowneKA

2001 Unlocking the secrets of cytotoxic granule proteins. J Leukoc Biol 70 18 29

28. CatalfamoM

HenkartPA

2003 Perforin and the granule exocytosis cytotoxicity pathway. Curr Opin Immunol 15 522 527

29. BettsMR

BrenchleyJM

PriceDA

De RosaSC

DouekDC

2003 Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281 65 78

30. BettsMR

KoupRA

2004 Detection of T-cell degranulation: CD107a and b. Methods Cell Biol 75 497 512

31. HamannD

BaarsPA

RepMH

HooibrinkB

Kerkhof-GardeSR

1997 Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 186 1407 1418

32. AppayV

DunbarPR

CallanM

KlenermanP

GillespieGM

2002 Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 8 379 385

33. BaarsPA

Ribeiro Do CoutoLM

LeusenJH

HooibrinkB

KuijpersTW

2000 Cytolytic mechanisms and expression of activation-regulating receptors on effector-type CD8+CD45RA+CD27− human T cells. J Immunol 165 1910 1917

34. GamadiaLE

RemmerswaalEB

WeelJF

BemelmanF

van LierRA

2003 Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. Blood 101 2686 2692

35. HardingFA

AllisonJP

1993 CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help. J Exp Med 177 1791 1796

36. KoulovaL

ClarkEA

ShuG

DupontB

1991 The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells. J Exp Med 173 759 762

37. IntlekoferAM

TakemotoN

WherryEJ

LongworthSA

NorthrupJT

2005 Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat Immunol 6 1236 1244

38. SullivanBM

JuedesA

SzaboSJ

von HerrathM

GlimcherLH

2003 Antigen-driven effector CD8 T cell function regulated by T-bet. Proc Natl Acad Sci U S A 100 15818 15823

39. SzaboSJ

SullivanBM

StemmannC

SatoskarAR

SleckmanBP

2002 Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295 338 342

40. TakahashiN

MatsumotoK

SaitoH

NankiT

MiyasakaN

2009 Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients. J Immunol 182 5515 5527

41. SylwesterAW

MitchellBL

EdgarJB

TaorminaC

PelteC

2005 Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 202 673 685

42. GarnettCT

ErdmanD

XuW

GoodingLR

2002 Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J Virol 76 10608 10616

43. De JongJC

WermenbolAG

Verweij-UijterwaalMW

SlaterusKW

Wertheim-Van DillenP

1999 Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J Clin Microbiol 37 3940 3945

44. LanzavecchiaA

SallustoF

2000 Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 290 92 97

45. SallustoF

LenigD

ForsterR

LippM

LanzavecchiaA

1999 Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401 708 712

46. FaintJM

AnnelsNE

CurnowSJ

ShieldsP

PillingD

2001 Memory T cells constitute a subset of the human CD8+CD45RA+ pool with distinct phenotypic and migratory characteristics. J Immunol 167 212 220

47. WillsMR

OkechaG

WeekesMP

GandhiMK

SissonsPJ

2002 Identification of naive or antigen-experienced human CD8(+) T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8(+) T cell response. J Immunol 168 5455 5464

48. RoosMT

van LierRA

HamannD

KnolGJ

VerhoofstadI

2000 Changes in the composition of circulating CD8+ T cell subsets during acute epstein-barr and human immunodeficiency virus infections in humans. J Infect Dis 182 451 458

49. MillerJD

van der MostRG

AkondyRS

GlidewellJT

AlbottS

2008 Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 28 710 722

50. AlmeidaJR

SauceD

PriceDA

PapagnoL

ShinSY

2009 Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. Blood 113 6351 6360

51. IntlekoferAM

TakemotoN

KaoC

BanerjeeA

SchambachF

2007 Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells. J Exp Med 204 2015 2021

52. JoshiNS

CuiW

ChandeleA

LeeHK

UrsoDR

2007 Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27 281 295

53. HwangES

HongJH

GlimcherLH

2005 IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508. J Exp Med 202 1289 1300

54. SzaboSJ

KimST

CostaGL

ZhangX

FathmanCG

2000 A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100 655 669

55. TakemotoN

IntlekoferAM

NorthrupJT

WherryEJ

ReinerSL

2006 Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation. J Immunol 177 7515 7519

56. ChattopadhyayPK

PriceDA

HarperTF

BettsMR

YuJ

2006 Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry. Nat Med 12 972 977

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 3
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#